Prevalence, sociodemographic distribution, treatment and control of diabetes mellitus in Panama

Diabetology and Metabolic Syndrome

Volumn 5, Issue 1, 2013, Pages

  McDonald, Anselmo J ^a   Montenegro G, Jose A ^b   Cruz G, Clara E ^c   Moreno De Rivera, Aida L ^a   Cumbrera O, Alberto ^a  

^a Gorgas Memorial Institute for Health Research   (Panama)

^b Santo Tomas Hospital   (Panama)

^c School of Statistics   (Panama)

Author keywords

Prevalence of diabetes mellitus in Panama; Sociodemographic distribution of diabetes mellitus; Treatment and control of diabetes mellitus

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADULT; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DIABETES CONTROL; DIABETES MELLITUS; DIET RESTRICTION; EDUCATIONAL STATUS; FEMALE; GLUCOSE BLOOD LEVEL; GROUPS BY AGE; HUMAN; INCOME; INDIGENOUS PEOPLE; MAJOR CLINICAL STUDY; MALE; MARRIAGE; PANAMA; PREVALENCE; PRIORITY JOURNAL; RESPONSE TIME; RISK FACTOR; RURAL AREA; SOCIAL CLASS; URBAN AREA;

EID: 84888364812     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-5-69     Document Type: Article

References (34)

1. The evolving diabetes burden in the United States. Engelgau M, Geiss L, Saaddine J, et al. Ann Intern Med 2004 140 945 950 10.7326/0003-4819-140-11- 200406010-00035 15172919 (Pubitemid 38685285)
2. Diagnosis and Classification of Diabetes Mellitus. American Diabetes Association, Diabetes Care 2010 33 62 S69 20042775
3. Epidemiology of Diabetes and Diabetes-Related Complications. Deshpande A, Harris-Hayes M, Schootman M, Phys Ther 2008 88 1254 1264 10.2522/ptj.20080020 18801858
4. Diabetes mellitus en adultos mexicanos. Resultados de la Encuesta Nacional de Salud 2000. Olaiz-Fernández G, Rojas R, Aguilar-Salinas C, Rauda J, Villalpando S, Salud Publica Mex 2007 49 331 S337
5. International Diabetes Federation, Diabetes Atlas. 5th Edition update 2012 http://www.idf.org/media-events/press-releases/2011/diabetes-atlas-5th- edition
6. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Third Report of the National Cholesterol Education Program (NCEP), Circulation 2002 106 3143 3421 12485966
7. Perspectives on diabetic retinopathy. Lloyd A, Am J Ophthalmol 2003 136 122 135 10.1016/S0002-9394(03)00219-8 12834680 (Pubitemid 36794505)
8. Incidence and prevalence of diabetes mellitus in the Americas. Barceló A, Rajpathak S, Rev Panam Salud Publica 2001 10 300 308 10.1590/S1020-49892001001100002 11774801 (Pubitemid 33143952)
9. Nephropathy in patients with type 2 diabetes mellitus. Ritz E, Reinhold S, N Engl J Med 1999 341 1127 1133 10.1056/NEJM199910073411506 10511612 (Pubitemid 29466226)
10. Magnitude of end-stage renal disease in IDDM: a 35 year follow-up study. Krolewski M, Eggers P, Warram J, Kidney Int 1996 50 2041 2046 10.1038/ki.1996.527 8943488 (Pubitemid 26417548)
11. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Selvin E, Erlinger T, Circulation 2004 110 6 738 743 10.1161/01.CIR.0000137913.26087.F0 15262830 (Pubitemid 39056275)
12. Ministerio de Sanidad y Consumo, Centro de publicaciones España: Estrategia en diabetes del Sistema Nacional de Salud 2007
13. Economics Consecuenses of Diabetes Mellitus in US in 1997. American Diabetes Association, American Diabetes Association 1998 1 14
14. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Harris M, Klein R, Welborn T, Knuiman M, Diabetes Care 1992 15 815 819 10.2337/diacare.15.7.815 1516497
15. Heart Disease and Stroke Statistics-2011 Update: A Report From the American Heart Association. Roger V, Go A, Lloyd-Jones D, et al. Circulation 2011 123 18 e209 10.1161/CIR.0b013e3182009701 21160056
16. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group, Lancet 1998 352 837 853 9742976
17. World Health Organization, The top 10 causes of death http://who.int/mediacentre/factsheets/fs310/en/
18. Contraloría General de la República, Instituto Nacional de Estadística y Censo, Estadísticas vitales. Defunciones en la República, por sexo, según edad y principales causas de muerte Panamá: Año 2007-2011
19. Wild S, Roglic G, Green A, Sicree R, King H, Global Prevalence of Diabetes. Diabetes Care 2004 27 1047 1053
20. Standards of Medical Care in Diabetes-2012. American Diabetes Association, Diabetes Care 2012 35 4 S10 22187471
21. Use of Glycated Hemoglobin (A1C) in the Diagnosis of Type 2 Diabetes Mellitus in Adults. Goldenberg R, Cheng A, Punthakee Z, Clement M, Canadian Journal of Diabetes 2011 35 247 249 10.1016/S1499-2671(11)53006-0
22. Los valores P y los intervalos de confianza: ¿en qué confiar? Clark M, Rev Panam Salud Publica 2004 15 293 296 10.1590/S1020- 49892004000500001 15231074 (Pubitemid 38856444)
23. Intervalos de confianza para las estimaciones de proporciones y las diferencias entre ellas. Newcombe R, Merino C, Interdisciplinaria 2006 23 141 154
24. Epidemiología de la Diabetes Mellitus en Latinoamérica. Asociación Latinoamericana de Diabetes, Revista de la Asociación Latinoamericana de Diabetes 2000 1 116 119
25. Prevalencia de diabetes en una población adulta de Madrid (España). Rosado J, Martínez M, Mantilla T, et al. Gac Sanit 2012 26 243 250 10.1016/j.gaceta.2011.09.013 22112716
26. Population-Based Study of Diabetes and Risk Characteristics in Turkey. Satman I, Yilmaz T, Senġul A, et al. Diabetes Care 2002 25 1551 1555 10.2337/diacare.25.9.1551 12196426 (Pubitemid 41071110)
27. Prevalence and distribution of type 2 diabetes mellitus in Mexican adult population. A probabilistic survey. Villalpando S, De la Cruz V, Rojas R, et al. Salud Publica Mex 2010 52 19 S26 20585724
28. Prevalence of Diabetes and Intermediate Hyperglycemia Among Adults From the First Multinational Study of Noncommunicable Disease in Six Central American Countries. The Central America Diabetes Iniciative (CAMDI). Barcelo A, Gregg E, Gerzoff R, et al. Diabetes Care 2012 35 738 740 10.2337/dc11-1614 22323417
29. Gómez B, González B, Luque H, Mc Donald A, Moreno DeRivera A, Roa R, Encuesta Nacional de Salud y Calidad de Vida Panamá: Instituto Conmemorativo Gorgas de Estudios de la Salud 2009
30. Dietary fat and meat intake in relation to risk of type 2 diabetes in men. Van Dam R, Willett W, Rimm E, Stampfer M, Hu F, Diabetes Care 2002 25 417 424 10.2337/diacare.25.3.417 11874924 (Pubitemid 41103330)
31. Percepción de riesgo familiar a desarrollar diabetes mellitus. Castillo-Arriaga A, Delgado-Sánchez V, Carmona-Suazo J, Rev Med Inst Mex Seguro Soc 2006 44 505 510 17346451
32. Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach. Insuchi S, Bergenstal R, Buse J, et al. Diabetes Care 2012 35 1364 1379 10.2337/dc12-0413 22517736
33. Tratamiento de la diabetes mellitus: objetivos generales y manejo en la práctica clínica. Simó R, Hernández C, Rev Esp Cardio 2002 55 845 860 10.1016/S0300-8932(02)76714-6
34. Poor Control of Risk Factors for Vascular Disease Among Adults With Previously Diagnosed Diabetes. Saydah S, Fradkin J, Cowie C, JAMA 2004 291 335 342 10.1001/jama.291.3.335 14734596 (Pubitemid 38101606)